Effect of omalizumab on seasonal exacerbations in adolescents and adults with moderate-to-severe allergic asthma

The Inner-City Anti-IgE Therapy for Asthma (ICATA) study showed that seasonal asthma exacerbation patterns, with peaks in fall and spring, were largely eliminated in children with persistent asthma after omalizumab treatment. This effect has not been examined in adolescents/adults.

Source: Annals of Allergy, Asthma and Immunology - November 1, 2018 Category: Allergy & Immunology Authors: J. Corren, T. Casale, T. Haselkorn, M. Yang, A. Iqbal, B. Ortiz, W. Busse Tags: A202 Source Type: research